Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

ACUT ACCUSTEM SCIENCES INC

Watchlist
0.961
+0.056+6.19%
Close  02/03 16:00 ET
High
1.100
Open
0.880
Turnover
10.12K
Low
0.800
Pre Close
0.905
Volume
11.10K
Market Cap
0
P/E(TTM)
0.00
52wk High
2.300
Shares
0
P/E(Static)
0.00
52wk Low
0.261
Float Cap
0
Bid/Ask %
0.00%
Historical High
2.300
Shs Float
0
Volume Ratio
0.76
Historical Low
0.261
Dividend TTM
--
Div Yield TTM
--
P/B
0.00
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.00%
Amplitude
33.15%
Avg Price
0.911
Lot Size
1
Float Cap
0
Bid/Ask %
0.00%
Historical High
2.300
Shs Float
0
Volume Ratio
0.76
Historical Low
0.261
Dividend TTM
--
P/B
0.00
Dividend LFY
--
Turnover Ratio
0.00%
Amplitude
33.15%
Avg Price
0.911
Lot Size
1
Price Forecast

News

Comment

Company Overview More
AccuStem Sciences, Inc. engages in medical practice activities. It owns the breast cancer diagnostic StemPrintER and the SPARE genomics-based personalized medicine business. The StemPrintER is a multi-gene prognostic assay intended to predict the risk of recurrence of R+/HER2- breast cancer, and Spare, a derivative of StemPrintER, combines StemPrintER with two clinical markers. The firm anticipates this prognostic test to be used in conjunction with clinical evaluation to identify those patients at increased risk for early and late metastasis. The company was founded on June 5, 2020 and is headquartered in New York, NY.
CEO: --
Market: Pink Market
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist